Home  /  Resource Library  /  Venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized phase 3 CLL14 study

Venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized phase 3 CLL14 study

Long term results of a study investigating venetoclax combined with obinutuzumab for first line treatment of CLL.